Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Coronavirus Infection
Interventions
DRUG

Nitazoxanide 500Mg Oral Tablet

Health workers affected by SARS-CoV-2 will receive the next doses of nitazoxanide: 500 mg every 6 hour for two days and then every 12 hours for four days.

Trial Locations (1)

50130

"Materno-Perinatal Hospital Mónica Pretelini", Toluca

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Laboratorios Liomont

INDUSTRY

lead

Materno-Perinatal Hospital of the State of Mexico

OTHER